 |
|
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study
Vy H. Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen
Clin Mol Hepatol. 2023;29(4):1002-1012. Published online 2023 Sep 11 DOI: https://doi.org/10.3350/cmh.2023.0205
|
|
Citations to this article as recorded by
 Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Soroor Owrangi, James M. Paik, Pegah Golabi, Leyla de Avila, Ryuki Hashida, Ariana Nader, Annette Paik, Linda Henry, Zobair M. Younossi
Alimentary Pharmacology & Therapeutics.2025; 61(3): 433. CrossRef Statin use and liver-related prognosis among patients with MASLD
Byungyoon Yun, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin-Ha Yoon
JHEP Reports.2025; 7(4): 101313. CrossRef Ethnic differences in metabolic and histologic features among White, Hispanic, Black and Asian patients with metabolic-associated Steatotic liver disease: A network meta-analysis
Limin Lin, Jiaming Lai, Ling Luo, Junzhao Ye, Bihui Zhong
Annals of Hepatology.2025; 30(2): 101780. CrossRef Representation of Sex, Race and Ethnicity in MASH Randomised Controlled Trials: A Systematic Review and Meta‐Analysis
Matheus Souza, Lubna Al‐Sharif, Ivanna Diaz, Samira Mohamad Khalil, Xiu‐He Lv, Alessandro Mantovani, Cristiane Alves Villela‐Nogueira
Liver International.2025;[Epub] CrossRef Differential Characteristics and Survival Outcomes of Patients With Cirrhosis According to Underlying Liver Aetiology
Yu Shi, Nicholas Chien, Ashley Fong, Vy H. Nguyen, Surya Teja Gudapati, Angela Chau, Sally Tran, Linda Henry, Ramsey Cheung, Changqing Zhao, Minjuan Jin, Mindie H. Nguyen
Alimentary Pharmacology & Therapeutics.2025;[Epub] CrossRef Sex and Race-Ethnic Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis of 40,166 Individuals
Clarissa Elysia Fu, Margaret Teng, Daniel Tung, Vijay Ramadoss, Christen Ong, Benjamin Koh, Wen Hui Lim, Darren Jun Hao Tan, Jia Hong Koh, Benjamin Nah, Nicholas Syn, Nobuharu Tamaki, Mohammad Shadab Siddiqui, Karn Wijarnpreecha, George N. Ioannou, Atsush
Digestive Diseases and Sciences.2024; 69(9): 3195. CrossRef Intervening on Metabolic Dysfunction-Associated Steatotic Liver Disease in Latino/a and Black Patients with Diabetes: A Feasibility Pilot
Anastasia-Stefania Alexopoulos, Susanne Danus, Alice Parish, Maren K. Olsen, Bryan C. Batch, Connie R. Thacker, Cynthia A. Moylan, Matthew J. Crowley
Diabetes Therapy.2024; 15(11): 2417. CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study
Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon, Hyung Ho Lee, Heejoo Park, Jian Lee, Youngsun Park, Byungyoon Yun, Jinsoo Chung
Cancers.2024; 16(18): 3161. CrossRef Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease among an Iranian Adult Population with Ethnic and Genetic Diversity: Results of the PolyIran-Liver Study
Elham Jafari, Shahin Merat, Amir Anoushiravani, Amir Reza Radmard, Gholamreza Roshandel, Maryam Sharafkhah, Masoud Khoshnia, Alireza Nateghi, Abolfazl Shiravi Khuzani, Hossein Poustchi, Reza Malekzadeh
Middle East Journal of Digestive Diseases.2024; 16(2): 86. CrossRef Disparities in Heart Failure Deaths among Patients with Cirrhosis
Benjamin Grobman, Arian Mansur, Christine Y. Lu
Journal of Clinical Medicine.2024; 13(20): 6153. CrossRef Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease outcomes: A call for culturally sensitive interventions: Editorial on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and e
Jae Hyun Bae
Clinical and Molecular Hepatology.2024; 30(4): 665. CrossRef Differences in major adverse cardiovascular events of metabolic dysfunction-associated steatotic liver disease by race and ethnicity: Letter to the editor on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and eth
Hui-Chin Chang, Wen-Chieh Liao, Yi-Jen Fang, Shiu-Jau Chen, Shuo-Yan Gau
Clinical and Molecular Hepatology.2024; 30(4): 978. CrossRef Reply to correspondence on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
Jae Hyun Bae
Clinical and Molecular Hepatology.2024; 30(4): 1047. CrossRef Correspondence to editorial on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
Vy H. Nguyen, Mindie H. Nguyen
Clinical and Molecular Hepatology.2024; 30(4): 1000. CrossRef
|